Ramya Muddasani
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Multiple Myeloma Research and Treatments 2
- Acute Myeloid Leukemia Research 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 2
- Co-authors
- Gary G. Lu (5 shared papers)Sumanta Kumar Pal (8 shared papers)Alex Chehrazi‐Raffle (6 shared papers)Zeynep Büşra Zengin (6 shared papers)Luis Alfredo Meza (6 shared papers)Ming Zhao (2 shared papers)Jaffer A. Ajani (2 shared papers)Qingyi Wei (2 shared papers)
- Journals
- Cancers (3 papers)Urologic Oncology Seminars and Original Investigations (2 papers)JCO Precision Oncology (2 papers)The American Journal of Gastroenterology (1 paper)Archives of Pathology & Laboratory Medicine (1 paper)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Ramya Muddasani
24 papers receiving 646 citations
Ramya Muddasani's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 239
- Biological Psychiatry 17
- Cancer Research 92
- Hematology 63
- Biotechnology 48
Countries citing papers authored by Ramya Muddasani
This map shows the geographic impact of Ramya Muddasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramya Muddasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramya Muddasani more than expected).
Fields of papers citing papers by Ramya Muddasani
This network shows the impact of papers produced by Ramya Muddasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramya Muddasani. The network helps show where Ramya Muddasani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ramya Muddasani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial Hit paper breakdown → | 2022 | 392 |
| 2 | 2010 | 47 | |
| 3 | 2013 | 32 | |
| 4 | 2013 | 29 | |
| 5 | 2021 | 21 | |
| 6 | 2013 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2023 | 16 | |
| 9 | 2013 | 14 | |
| 10 | 2010 | 12 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2018 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2015 | 3 | |
| 20 | 2024 | 2 |
About Ramya Muddasani
Ramya Muddasani is a scholar working on Hematology, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 654 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Renal cell carcinoma treatment (3 papers), Lung Cancer Research Studies (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (239 citations), Biological Psychiatry (17 citations), Cancer Research (92 citations), Hematology (63 citations) and Biotechnology (48 citations). Ramya Muddasani has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Gary G. Lu, Sumanta Kumar Pal, Alex Chehrazi‐Raffle, Zeynep Büşra Zengin, Luis Alfredo Meza, Ming Zhao, Jaffer A. Ajani, Qingyi Wei, Li‐E Wang and Dongfeng Tan. Their work appears in journals such as Cancers, Urologic Oncology Seminars and Original Investigations, JCO Precision Oncology, The American Journal of Gastroenterology and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.